Boji Medical & Technology Co., Ltd. logo

Boji Medical & Technology Co., Ltd. (300404)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
11. 79
+0.56
+4.9866%
¥
3.83B Market Cap
- P/E Ratio
0.01% Div Yield
53M Volume
- Eps
¥ 11.23
Previous Close
Add Transaction
Day Range
11.01 12.43
Year Range
8.15 13.15
Want to track 300404 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

300404 closed today higher at ¥11.79, an increase of 4.9866% from yesterday's close, completing a monthly increase of 34.1297% or ¥3. Over the past 12 months, 300404 stock gained 25.4255%.
300404 is not paying dividends to its shareholders.
The last earnings report, released on May 16, 2025, exceeded the consensus estimates by 0.0103%. On average, the company has surpassed earnings expectations by 0.0228%, based on the last three reports.
Boji Medical & Technology Co., Ltd. has completed 4 stock splits, with the recent split occurring on Jun 02, 2022.
The company's stock is traded on one exchange.

300404 Chart

People also search for

Guangzhou Wondfo Biotech Co., Ltd.
¥ 17.74
-0.8385%
China Reform Health Management Co., Ltd.
¥ 7.42
-1.5915%
Acro Biosystems Co., Ltd.
¥ 82.3
+5.9202%
EIT Environmental Development Group Co., Ltd.
¥ 16.48
-1.3764%
Huapont Life Sciences Co., Ltd.
¥ 4.5
+0.6711%

Boji Medical & Technology Co., Ltd. (300404) FAQ

What is the stock price today?

The current price is ¥11.79.

On which exchange is it traded?

Boji Medical & Technology Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 300404.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.01%.

What is its market cap?

As of today, the market cap is 3.83B.

Has Boji Medical & Technology Co., Ltd. ever had a stock split?

Boji Medical & Technology Co., Ltd. had 4 splits and the recent split was on Jun 02, 2022.

Boji Medical & Technology Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Tingchun Wang M.D., Ph.D. CEO
XSHE Exchange
CNE100001Y00 ISIN
CN Country
1,205 Employees
17 Jun 2026 Last Dividend
20 Oct 2015 Last Split
- IPO Date

Overview

Boji Medical Technology Co., Ltd., initially known as Guangzhou Boji Medical & Biotechnological Co., Ltd., is a reputable entity that specializes in offering professional contract research services tailored for the pharmaceutical sector, both within China and on an international level. Founded in 1998 and having its headquarters situated in Guangzhou, China, the company has established itself as a key player in the research, development, and production of drugs and medical devices. In September 2021, it underwent a strategic rebranding, adopting its current name to reflect its broadened scope and commitment to innovation in medical technology. Boji Medical Technology plays a pivotal role in advancing pharmaceutical research by providing a comprehensive range of services from pre-clinical trials to clinical research and beyond.

Products and Services

  • Pre-clinical Research

    Boji Medical Technology offers extensive services in pre-clinical research, ensuring that new drugs and medical devices are scrutinized under laboratory conditions to establish their safety and efficacy before they proceed to clinical trials. This foundational step is crucial for identifying potential therapeutic benefits and minimizing risks.

  • Clinical Research

    Once pre-clinical testing is satisfactorily completed, Boji assists in the advancement of drugs and devices through clinical research. This phase involves testing on human subjects to gather critical data on effectiveness, side effects, and the optimal dosing regimen. Boji's expertise ensures these trials are conducted with the utmost precision and regulatory compliance.

  • Clinical Drug Production

    The company also specializes in the production of clinical-grade drugs, adhering to stringent manufacturing practices. This includes the production of small batches for use in clinical trials, ensuring that every stage of drug development is meticulously overseen for quality and safety.

  • Product Test and Pilot Test Scale-up

    Boji offers testing services for medical products alongside pilot test scale-ups, which are essential for transitioning from lab-scale production to larger batches. This process involves refinement of the production process to ensure it is scalable and economically viable for commercial production.

  • Process Verification Batch Production

    In alignment with regulatory requirements, the company provides services for process verification through batch production. This critical step verifies that the manufacturing process is reproducible and produces a consistent product batch after batch.

  • Drug Registration and Approval

    Boji facilitates the drug registration and approval process, leveraging its expertise to navigate the complex regulatory landscape. This service ensures that drugs and medical devices comply with all regulatory standards necessary for market entry.

  • Screening, Evaluation, Verification, and Trading of Phased Technological Achievements

    Beyond traditional research and development services, Boji engages in the screening, evaluation, verification, and trading of technological achievements acquired during the new drug development process. This aspect of their business focuses on maximizing the value of innovative discoveries and ensuring they reach their full potential in the marketplace.

Contact Information

Address: Building A, Vanke Cloud Plaza, Guangzhou, China, 510000
Phone: 86 40 0002 0628